Legis Daily

Affordable Drug Manufacturing Act of 2019

USA116th CongressHR-5501| House 
| Updated: 12/20/2019
Janice D. Schakowsky

Janice D. Schakowsky

Democratic Representative

Illinois

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Affordable Drug Manufacturing Act of 2019 This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 19, 2019
Introduced in House
Dec 19, 2019
Referred to the House Committee on Energy and Commerce.
Dec 20, 2019
Referred to the Subcommittee on Health.
Jan 8, 2020

Latest Companion Bill Action

S 116-3162
Introduced in Senate
  • December 19, 2019
    Introduced in House


  • December 19, 2019
    Referred to the House Committee on Energy and Commerce.


  • December 20, 2019
    Referred to the Subcommittee on Health.


  • January 8, 2020

    Latest Companion Bill Action

    S 116-3162
    Introduced in Senate

Health

Related Bills

  • S 116-3162: Affordable Drug Manufacturing Act of 2020
Competition and antitrustCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFederal officialsGovernment employee pay, benefits, personnel managementHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth programs administration and fundingInflation and pricesLicensing and registrationsManufacturingPrescription drugsPublic contracts and procurementPublic participation and lobbying

Affordable Drug Manufacturing Act of 2019

USA116th CongressHR-5501| House 
| Updated: 12/20/2019
Affordable Drug Manufacturing Act of 2019 This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 19, 2019
Introduced in House
Dec 19, 2019
Referred to the House Committee on Energy and Commerce.
Dec 20, 2019
Referred to the Subcommittee on Health.
Jan 8, 2020

Latest Companion Bill Action

S 116-3162
Introduced in Senate
  • December 19, 2019
    Introduced in House


  • December 19, 2019
    Referred to the House Committee on Energy and Commerce.


  • December 20, 2019
    Referred to the Subcommittee on Health.


  • January 8, 2020

    Latest Companion Bill Action

    S 116-3162
    Introduced in Senate
Janice D. Schakowsky

Janice D. Schakowsky

Democratic Representative

Illinois

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 116-3162: Affordable Drug Manufacturing Act of 2020
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Competition and antitrustCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFederal officialsGovernment employee pay, benefits, personnel managementHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth programs administration and fundingInflation and pricesLicensing and registrationsManufacturingPrescription drugsPublic contracts and procurementPublic participation and lobbying